Skip to content

Investment Opportunity

Investing in Us

Congenica is a digital health company enabling genomic medicine.

We are building a future where clinical genomics is fully integrated into healthcare. A time when personalized decisions and treatments, guided by genomic information, are routinely used to transform the health and wellness of individuals around the world.

Our technology is a pioneering software solution interpreting genomic data faster than ever before, empowering healthcare professionals globally to translate genomic data into actionable information and provide life-changing answers.

Receive our newsletter

Company highlights

Headquartered at the world leading Wellcome Genome Campus, home to some of the world’s foremost organizations in genomics and computational biology

The company has a global footprint with teams and clients in the UK, US and China

Commercial partnerships established with international Centers of Excellence

Congenica is the exclusive decision support platform provider for the UK NHS Genomic Medicine Service

Transforming lives

It is estimated that 5.3% of newborns will suffer from a genetic disorder.1

Worldwide, there are 350m people with rare diseases, 80% of which are genetic in origin.

There are over 17 million new cases of cancer each year.2

With our scalable software, we have the potential to advance clinical understanding of genetic diseases and optimize patient outcomes on a global scale.3

Congenica is developing world-leading scalable technology so that healthcare professionals can make important clinical decisions which will transform the lives of patients and their families. As the use of genomic information becomes the standard in facilitating personalized health, our integrated global solutions will play a key role at the center of healthcare.

David Atkins, PhD
Chief Executive Officer

Commercial growth

Market expansion

AI-enabled data strategy

If you would like to receive further company information
or have any questions, please get in touch.

Contact us


  1. Verma, I.C., Puri, R.D. Global burden of genetic disease and the role of genetic screening. Semin Fetal Neonatal Med. 2015 Oct;20(5):354-63.
  2. Global Genes. RARE Facts, viewed 17th May 2019.
  3. Cancer Research UK. Worldwide cancer statistics, viewed 17th May 2019.
pinterest Twitter Facebook email LinkedIn < Back to top